Literature DB >> 11813565

Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype.

R Fiocca1, O Luinetti, L Villani, L Mastracci, P Quilici, F Grillo, G N Ranzani.   

Abstract

Gastric cancer develops through the accumulation of multiple genetic lesions that involve oncogenes, tumor suppressor genes and DNA mismatch repair genes. Lauren's classification of gastric carcinoma does not correlate with cellular phenotypes expressed by neoplastic cells and gastric and intestinal cell differentiation markers are widely expressed in both types (intestinal and diffuse) of gastric carcinoma. In contrast, the study of the correlation between morphologic events and genetic alterations, which come about in the cancerogenetic process, seems to indicate the existence of distinct cancerogenetic pathways for the intestinal (or glandular) and diffuse type carcinoma, both originating from a HP-positive gastritis. In particular there seem to be three different profiles of cancerogenesis: 1) p53 mutations which accompany the onset of dysplasia and intestinal-type carcinoma; 2) DNA repair mechanism alterations conditioning microsatellite instability, seem mutually exclusive with regards to p53 mutations. Microsatellite instability correlates with antrally located intestinal-type carcinoma, with little metastatic tendency and a better prognosis; microsatellite instability frequently involves the TGF beta RII, IGF II R genes or the BAX proapoptotic gene, in as much as these contain microsatellite sequences; 3) alterations of E-cadherin, both with regards to mutations and abnormal expression. These lead to junctional and cell polarity loss and are primarily associated with diffuse type carcinoma, which is characterized by poorly cohesive neoplastic cells. Some tumors, initially arising as intestinal-type (glandular structure), acquire a mixed histotype during neoplastic progression, in which both the typical alterations of the intestinal cancerogenesis (p53, microsatellite instability) and those of the diffuse carcinoma (E-cadherin) coexist. The identification of a mixed histotype could have importance both in epidemiologic, pathogenetic and prognostic terms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11813565

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  13 in total

1.  Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery.

Authors:  Wen-Liang Fang; Shih-Ching Chang; Yuan-Tzu Lan; Kuo-Hung Huang; Jen-Hao Chen; Su-Shun Lo; Mao-Chih Hsieh; Anna Fen-Yau Li; Chew-Wun Wu; Shih-Hwa Chiou
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

2.  Detection of microsatellite instability in gastric cancer and dysplasia tissues.

Authors:  Bing Li; Hong-Yi Liu; Shao-Hua Guo; Peng Sun; Fang-Ming Gong; Bao-Qing Jia
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy.

Authors:  Wen Quan Jonathan Goh; Ghim Siong Ow; Vladimir A Kuznetsov; Shirly Chong; Yoon Pin Lim
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

4.  Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma.

Authors:  Tsutomu Namikawa; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 5.  Microsatellite instability in gastrointestinal tract cancers: a brief update.

Authors:  Shinya Oda; Yan Zhao; Yoshihiko Maehara
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

6.  A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?

Authors:  Domenico Ciliberto; Nicoletta Staropoli; Francesca Caglioti; Simona Gualtieri; Lucia Fiorillo; Silvia Chiellino; Antonina Maria De Angelis; Francesco Mendicino; Cirino Botta; Michele Caraglia; Pierfrancesco Tassone; Pierosandro Tagliaferri
Journal:  Cancer Biol Ther       Date:  2015-06-10       Impact factor: 4.742

7.  Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer.

Authors:  Xiao-Mei Zhang; Xiao-Yan Wang; Shou-Rong Sheng; Jie-Ru Wang; Jiang Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

8.  Atomic Insight into the Altered O6-Methylguanine-DNA Methyltransferase Protein Architecture in Gastric Cancer.

Authors:  Naveed Anjum Chikan; Shoiab Bukhari; Nadeem Shabir; Asif Amin; Sheikh Shafi; Raies Ahmad Qadri; Trupti Navin Chandra Patel
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

9.  High frequency of microsatellite instability in intestinal-type gastric cancer in Korean patients.

Authors:  Won Hyuk Choe; Sun-Young Lee; Jun Haeng Lee; Sang Goon Shim; Young-Ho Kim; Poong-Lyul Rhee; Jong Chul Rhee; Chang-Seok Ki; Jong-Won Kim; Sang Yong Song; Jae J Kim
Journal:  Korean J Intern Med       Date:  2005-06       Impact factor: 2.884

10.  Clinicopathologic and immunohistochemistry characterization of synchronous multiple primary gastric adenocarcinoma.

Authors:  Ulysses Ribeiro; Uana M Jorge; Adriana V Safatle-Ribeiro; Osmar K Yagi; Cristovam Scapulatempo; Rodrigo O Perez; Carlos E P Corbett; Venâncio A F Alves; Bruno Zilberstein; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.